国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Pyrococcus kodakaraensis Acylphosphatase (acyP) CSB-YP689287FHY
CSB-EP689287FHY
CSB-BP689287FHY
CSB-MP689287FHY
CSB-EP689287FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 30S ribosomal protein S3P (rps3p) CSB-YP689288FHY
CSB-EP689288FHY
CSB-BP689288FHY
CSB-MP689288FHY
CSB-EP689288FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 50S ribosomal protein L10e (rpl10e) CSB-YP689289FHY
CSB-EP689289FHY
CSB-BP689289FHY
CSB-MP689289FHY
CSB-EP689289FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 1,4-alpha-glucan branching enzyme TK1436 (TK1436), partial CSB-YP689290FHY
CSB-EP689290FHY
CSB-BP689290FHY
CSB-MP689290FHY
CSB-EP689290FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis 50S ribosomal protein L37Ae (rpl37ae) CSB-YP689291FHY
CSB-EP689291FHY
CSB-BP689291FHY
CSB-MP689291FHY
CSB-EP689291FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis S-adenosylmethionine decarboxylase proenzyme (speH) CSB-YP689292FHY
CSB-EP689292FHY
CSB-BP689292FHY
CSB-MP689292FHY
CSB-EP689292FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Translation initiation factor 2 subunit alpha (eif2a) CSB-YP689293FHY
CSB-EP689293FHY
CSB-BP689293FHY
CSB-MP689293FHY
CSB-EP689293FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis DNA-directed RNA polymerase subunit L (rpoL) CSB-YP689294FHY
CSB-EP689294FHY
CSB-BP689294FHY
CSB-MP689294FHY
CSB-EP689294FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Phosphate import ATP-binding protein PstB (pstB) CSB-YP689295FHY
CSB-EP689295FHY
CSB-BP689295FHY
CSB-MP689295FHY
CSB-EP689295FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermococcus kodakarensis Endonuclease NucS (nucS) CSB-YP689296FHY
CSB-EP689296FHY
CSB-BP689296FHY
CSB-MP689296FHY
CSB-EP689296FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Protease HtpX homolog (htpX), partial CSB-YP689297FHY1
CSB-EP689297FHY1
CSB-BP689297FHY1
CSB-MP689297FHY1
CSB-EP689297FHY1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Putative HTH-type transcriptional regulatory protein TK0539 (TK0539) CSB-YP689298FHY
CSB-EP689298FHY
CSB-BP689298FHY
CSB-MP689298FHY
CSB-EP689298FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Nucleoside-triphosphatase THEP1 (TK0557) CSB-YP689299FHY
CSB-EP689299FHY
CSB-BP689299FHY
CSB-MP689299FHY
CSB-EP689299FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Prefoldin subunit beta (pfdB) CSB-YP689300FHY
CSB-EP689300FHY
CSB-BP689300FHY
CSB-MP689300FHY
CSB-EP689300FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Elongation factor 1-beta (ef1b) CSB-YP689301FHY
CSB-EP689301FHY
CSB-BP689301FHY
CSB-MP689301FHY
CSB-EP689301FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis UPF0130 protein TK0175 (TK0175) CSB-YP689302FHY
CSB-EP689302FHY
CSB-BP689302FHY
CSB-MP689302FHY
CSB-EP689302FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Phosphoribosylamine--glycine ligase (purD) CSB-YP689303FHY
CSB-EP689303FHY
CSB-BP689303FHY
CSB-MP689303FHY
CSB-EP689303FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Imidazole glycerol phosphate synthase subunit HisH (hisH) CSB-YP689304FHY
CSB-EP689304FHY
CSB-BP689304FHY
CSB-MP689304FHY
CSB-EP689304FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Quinolinate synthase A (nadA) CSB-YP689305FHY
CSB-EP689305FHY
CSB-BP689305FHY
CSB-MP689305FHY
CSB-EP689305FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus kodakaraensis Uridylate kinase (pyrH) CSB-YP689306FHY
CSB-EP689306FHY
CSB-BP689306FHY
CSB-MP689306FHY
CSB-EP689306FHY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>